5 Key Takeaways

• 1

  A randomized controlled trial is assessing whole-spine manual therapy for cervical vertigo, enrolling participants from March 2025 to December 2026.

• 2

  The study compares three approaches: synergistic manual therapy, cervical-only manual therapy, and a control group with no treatment.

• 3

  A total of 138 participants aged 18 to 75 will be randomly assigned to one of the three groups in a 1:1:1 ratio.

• 4

  Primary outcomes include changes in vertigo severity measured by the Dizziness Handicap Inventory, with secondary outcomes assessing blood flow and quality of life.

• 5

  Safety monitoring will track adverse events, and an independent committee will review serious adverse events throughout the trial.